Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer
Crossref DOI link: https://doi.org/10.1007/s10238-015-0394-x
Published Online: 2015-10-08
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyashita, Tomoharu
Miki, Kenji
Kamigaki, Takashi
Makino, Isamu
Nakagawara, Hisatoshi
Tajima, Hidehiro
Takamura, Hiroyuki
Kitagawa, Hirohisa
Fushida, Sachio
Ahmed, Ali K.
Duncan, Mark D.
Harmon, John W.
Ohta, Tetsuo
Text and Data Mining valid from 2015-10-08